Yüklüyor......
IL-32 expression indicates unfavorable prognosis in patients with colon cancer
Recently, interleukin (IL)-32 has been demonstrated to represent a novel biomarker for evaluating the prognosis of patients with gastric and lung cancer; however, its clinical significance in colon cancer remains unknown. In the present study, the IL-32 expression in 60 patients with colon cancer wa...
Kaydedildi:
| Yayımlandı: | Oncol Lett |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6447918/ https://ncbi.nlm.nih.gov/pubmed/30988822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10136 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|